CARM1 and cancer: These functionaloutcomes demonstrate that natural product-mediated CARM1 degradationeffectively inhibits key oncogenic processes associated with CARM1activity, including anchorage-independent growth and cellular migration,implicating therapeutic potential for these compound scaffolds inbreast cancer treatment.